InfoBionic, an emerging medical technology company that has developed MoMe™—MonitorMe, a cloud-based SaaS service that empowers cardiologists to better detect and monitor cardiac events such as arrhythmias—announced today that its President and CEO, Nancy Briefs, will present the InfoBionic opportunity next Tuesday, January 8^th, at the sixth annual ‘OneMedForum’ investor conference taking place at The Sir Francis Drake Hotel. Ms. Briefs’ presentation is scheduled for 11:20 a.m. PST.

InfoBionic intends is to play a leading role in the transformation of healthcare delivery by providing anywhere-anytime-access to cardiac event monitoring with higher quality and lower cost than is currently available. InfoBionic’s platform has broad applicability in mHealth but the company selected arrhythmia detection as its initial business focus because it is one of the few mHealth opportunities with reimbursement already in place, and it is ripe for process innovation. MoMe™ has a clear regulatory path and the company expects to launch in 2013 in both US and EU.

“Because arrhythmias are transient events, real-time ambulatory monitoring is a critical component to the diagnosis and treatment of a patient’s arrhythmia,” said Nancy Briefs, CEO, InfoBionic. “Unfortunately, current ambulatory cardiac monitoring (Holter, event and MCT) relies on complex devices with antiquated technology or inefficient and ineffective monitoring systems to capture and analyze patient data.

“MoMe™ is a superior universal solution for ambulatory cardiac monitoring because we can do it faster, better and cheaper,” added Briefs, a serial entrepreneur responsible for developing and commercializing innovative, paradigm-shifting technologies with five prior medtech start-ups. “Unlike current mobile cardiac monitoring offerings, MoMe™ keeps data in the hands of physicians.”

The system uses proprietary algorithms to continually analyze data that can then be accessed anytime by a physician using a standard internet connection and a computer, mobile device or tablet.

Headquartered in Lowell, Mass., InfoBionic™ is a privately held, emerging mHealth leader in using mobile and wireless devices to improve health outcomes, healthcare services and health research. Its initial, proprietary cloud-based SaaS service, MoMe™ (MonitorMe), enables physicians to better detect and monitor cardiac arrhythmias.